MedTrace Logo

PGI2 Induced Headache and Cerebral Haemodynamics in Healthy Volunteers

NCT00291395 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2006-10-26

No results posted yet for this study

Summary

Before , during and after intravenous administration of PGI2 we score/measure headache, rCBF, blood flow in middle cerebral artery and diameter of superficial temporal artery/radial artery and correlate that to known patophysiology of headache to see if PGI2 is involved in headache pathophysiology.

Conditions

Interventions

DRUG

PGI2

Sponsors & Collaborators

  • Danish Headache Center

    lead OTHER

Principal Investigators

  • Troels Wienecke, MD · Danish Headache Center

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00291395 on ClinicalTrials.gov